Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents

Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents

Numerous angiogenesis-vascular targeting agents have been admitted to the ranks of cancer therapeutics; most of them are used in polytherapy regimens. This review will address recent progress together with our preclinical experience in combining angiogenesis inhibitors, mainly acting on VEGF/VEGFR p...

Full description

Bibliographic Details
Main Authors: Marta eCesca, Francesca eBizzaro, Massimo eZucchetti, Raffaella eGiavazzi
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-10-01
Series:Frontiers in Oncology
Subjects:
Angiogenesis Inhibitors
Paclitaxel
Tumor Microenvironment
Drug delivery
Combination therapies
receptor tyrosin kinase inhibitors
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00259/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00259/full

Similar Items